(Q43115816)

14 November 2017

title

Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106. (English)

1 reference

14 November 2017

0 references

chronic schizophrenia

1 reference

Akihiro Takano

1

1 reference

14 November 2017

Ryosuke Arakawa

2

1 reference

14 November 2017

Hiroshi Ito

3

1 reference

14 November 2017

Amane Tateno

4

1 reference

14 November 2017

Hidehiko Takahashi

5

1 reference

14 November 2017

Ryohei Matsumoto

6

1 reference

14 November 2017

Yoshiro Okubo

7

1 reference

14 November 2017

Tetsuya Suhara

8

1 reference

14 November 2017

publication date

30 March 2010

1 reference

The International Journal of Neuropsychopharmacology

14 November 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

14 November 2017

volume

13

1 reference

14 November 2017

issue

7

1 reference

14 November 2017

page(s)

943-950

1 reference

Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

Risperidone significantly inhibits interferon-gamma-induced microglial activation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

Quantitative analysis for estimating binding potential of the peripheral benzodiazepine receptor with [(11)C]DAA1106.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

Neuroinflammation in schizophrenia-related psychosis: a PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

The antipsychotic spiperone attenuates inflammatory response in cultured microglia via the reduction of proinflammatory cytokine expression and nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

Inhibition of lipopolysaccharide-induced cyclooxygenase-2, tumor necrosis factor-alpha and [Ca2+]i responses in human microglia by the peripheral benzodiazepine receptor ligand PK11195.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

Binding characteristics of [3H]DAA1106, a novel and selective ligand for peripheral benzodiazepine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

In-vivo measurement of activated microglia in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

[(11)C]DAA1106: radiosynthesis and in vivo binding to peripheral benzodiazepine receptors in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

Acute and repeated swim stress effects on peripheral benzodiazepine receptors in the rat hippocampus, adrenal, and kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

Increased binding of peripheral benzodiazepine receptor in Alzheimer's disease measured by positron emission tomography with [11C]DAA1106.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: evidence from activated microglial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

P-glycoprotein activity and biological response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

A review of MRI findings in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

Ten year progressive ventricular enlargement in schizophrenia: an MRI morphometrical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

Memory impairment correlates with increased S100B serum concentrations in patients with chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

Neuropharmacological profile of peripheral benzodiazepine receptor agonists, DAA1097 and DAA1106.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

COX-2 inhibition in schizophrenia and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

Novel peripheral benzodiazepine receptor ligand [11C]DAA1106 for PET: an imaging tool for glial cells in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

Longitudinal study of brain morphology in first episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

Peripheral benzodiazepine receptors reflect trait (early handling) but not state (avoidance learning).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

Chlorpromazine and loxapine reduce interleukin-1beta and interleukin-2 release by rat mixed glial and microglial cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

Flupentixol and trifluperidol reduce secretion of tumor necrosis factor-alpha and nitric oxide by rat microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000313

10.1017/S1461145710000313

21 January 2018

Identifiers

DOI

1 reference

release_bjidqzxacbcgjepwt6324nx6mq

14 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bjidqzxacbcgjepwt6324nx6mq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference